High throughput development of TCR-mimic antibody that targets survivin-2B80-88/HLA-A*A24 and its application in a bispecific T-cell engager
Abstract Intracellular tumor-associated antigens are targeted by antibodies known as T-cell receptor mimic antibodies (TCRm-Abs), which recognize T-cell epitopes with better stabilities and higher affinities than T-cell receptors. However, TCRm-Abs have been proven difficult to produce using convent...
Guardado en:
Autores principales: | Nobuyuki Kurosawa, Yuka Wakata, Kenta Ida, Aki Midorikawa, Masaharu Isobe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c7b6f569eba748bc82727b189112c54a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival
por: Guilhem Richard, et al.
Publicado: (2021) -
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML
por: Dyantha I. van der Lee, et al.
Publicado: (2021) -
Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis
por: Marianna Miliaraki, et al.
Publicado: (2021) -
NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCRα and β sequence data
por: Alessandro Montemurro, et al.
Publicado: (2021) -
Expression of CD80 and HLA-DR molecules on blood monocytes in patients with pulmonary tuberculosis
por: E. G. Churina, et al.
Publicado: (2021)